The alliance between AbbVie and Calico dates back to 2014, just a year after it was launched by Alphabet's Google unit, when ...

AbbVie is ending an eleven-year agreement with Alphabet’s Calico Labs, according to an internal email obtained by Stat News.

AbbVie (ABBV) stock is in focus as the company ends its decade-long R&D deal with Calico, an Alphabet (GOOG)-backed startup ...

An 11-year, $2 billion partnership has yet to produce an approved drug, but five attempts are in clinical trials.

AbbVie and Calico first inked their partnership in 2014 with up to $1.5 billion in funding to advance therapies for diseases, ...

AbbVie is ending a decade-long partnership with Calico Life Sciences, an Alphabet-funded biotech company focused on aging ...

ADPKD is the most common inherited kidney disease worldwide. (1) Characterized by the development and growth of fluid-filled cysts in both kidneys, the progressive disease leads to kidney failure in ...

AbbVie (ABBV) is ending its partnership with Alphabet (GOOG) (GOOGL)-funded biotech company Calico Life Sciences after a decade, STAT’s Damian ...

A UK team claims to have cracked one of life's oldest mysteries - how to stop the body breaking down with age - and is now ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti-IL-11 ...

Longevity hacks and body tracking have become an obsession for the super-rich. Now a young Australian is making millions by making it more affordable.

Critics, including some drugmakers, argue that new patent policies would make it more difficult for companies to bring ...